Vyndaqel 20 MG capsule UD 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FM2HV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Vyndaqel 20 mg capsule unit dose packages (120 count). This non-set-aside, firm fixed-price contract is scheduled for completion by February 4, 2026, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Vyndaqel is a prescription medication used to treat transthyretin cardiac amyloidosis, a serious cardiac condition, and represents the type of specialized pharmaceutical product that the Defense Logistics Agency procures to support military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive vehicle enabling Cencora to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor with significant federal contracting experience, AmerisourceBergen has demonstrated consistent capability to fulfill government medical procurement requirements through open competition and serves critical healthcare needs across the Department of Defense, Defense Health Agency, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FM2HV?
SPE2DR26FM2HV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM2HV worth?
The government has obligated $14,593 on SPE2DR26FM2HV.
Is contract SPE2DR26FM2HV an order under another contract?
Yes. SPE2DR26FM2HV is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2HV competed?
The extent of competition for SPE2DR26FM2HV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award